Ureteral Stents Market Size, Share & Trends Analysis Report By Material (Metallic, Polymer), By Application (Kidney Stones, Kidney Transplantation, Urinary Incontinence), By Region, And Segment Forecasts, 2025 - 2030

Ureteral Stents Market Size & Trends

The global ureteral stents market size was valued at USD 575.5 million in 2024 and is expected to grow at a CAGR of 6.9% from 2025 to 2030. This growth is attributed to the rising incidence of urological diseases, such as kidney stones and urinary tract infections, alongside an increasing geriatric population prone to such conditions. In addition, advancements in stent technology and materials enhance patient comfort and efficacy. Furthermore, the growth of healthcare infrastructure, particularly in developing regions, and a surge in kidney transplants also contribute significantly to market expansion.

A ureteral stent is a flexible, hollow tube inserted into the ureter to alleviate obstructions in urine flow and support proper kidney function. One end of the stent is positioned at the kidney, while the other extends into the bladder, effectively preventing urinary blockages and facilitating urine movement during normal flow disruption. These stents are typically inserted using a cystoscope, a specialized instrument that allows for precise placement.

The increasing prevalence of kidney disorders, rising geriatric population, urbanization trends, and sedentary lifestyles are major market growth drivers. Furthermore, dietary changes such as increased calcium consumption and higher intakes of animal protein negatively affect kidney health and contribute to the demand for ureteral stents. Vitamin supplements and other dietary factors also influence this trend.

Manufacturers are increasingly interested in developing new product lines that leverage advanced technologies to enhance stent performance and patient comfort. This focus on innovation propels market growth as healthcare providers seek effective solutions for managing kidney-related conditions. As healthcare systems continue to evolve and improve, the need for effective interventions to address urological issues will likely expand, indicating a promising future for the ureteral stents market. The combination of these factors suggests a dynamic landscape for patients and manufacturers in this vital area of healthcare.

Material Insights

Polymer ureteral stents led the market and accounted for the largest revenue share of 67.0% in 2024. This growth is attributed to advancements in materials that have led to the development of stents that are not only biocompatible but also flexible and lightweight, enhancing patient comfort during use. In addition, the increasing incidence of urological disorders, such as kidney stones and urinary tract infections, necessitates effective solutions like polymer stents. Furthermore, a rise in minimally invasive surgical techniques has boosted the demand for these stents, as they can be easily inserted and removed, reducing patient recovery time.

The metallic ureteral stents are expected to grow at a CAGR of 6.5% over the forecast period, owing to their durability and resistance to encrustation. These stents can remain in place for extended periods without frequent replacements, which benefits patients with chronic conditions. In addition, the rising number of kidney transplants and urological procedures also contributes to the demand for metallic stents. Furthermore, advancements in metal alloy technology have improved the performance of these stents, making them more effective in preventing complications such as migration and blockage. Moreover, the economic advantage of lower procedural costs associated with metallic stents than polymer options further drives their market growth.

Application Insights

Kidney stones dominated the market and accounted for the largest revenue share of 37.0% in 2024 attributed to the increasing prevalence of urolithiasis. In addition, factors such as sedentary lifestyles, poor dietary habits, and rising obesity rates contribute significantly to this condition. Furthermore, ureteroscopy and ureterorenoscopy procedures often necessitate using ureteral stents to manage stone fragments and prevent obstructions. Moreover, advancements in minimally invasive surgical techniques have further fueled demand for effective stenting solutions during treatment.

Urinary incontinence is expected to grow at a CAGR of 7.2% over the forecast period, owing to a rising aging population and increased conditions that lead to urinary dysfunction. In addition, factors such as obesity, neurological disorders, and pelvic floor weakening contribute to higher incidences of urinary incontinence. As awareness about treatment options grows, more patients are seeking interventions that include ureteral stents. Furthermore, advancements in stent design and materials have improved patient comfort and outcomes, encouraging healthcare providers to adopt these solutions more widely for managing urinary incontinence effectively.

Regional Insights

North America ureteral stents market dominated the global market and accounted for the largest revenue share of 36.3% in 2024 attributed to the high prevalence of urological disorders, including kidney stones and urinary tract infections. In addition, the region benefits from an established healthcare infrastructure and advanced medical technologies, facilitating effective treatment options. Furthermore, the aging population contributes to an increased incidence of kidney-related diseases, further driving demand. The presence of major market players and ongoing research and development initiatives also bolster the market's expansion in this region.

U.S. Ureteral Stents Market Trends

The ureteral stents market in the U.S. led the North American market and accounted for the largest revenue share in 2024, owing to its high healthcare expenditure and advanced medical facilities. In addition, the increasing number of kidney transplants and minimally invasive surgical procedures enhances the demand for ureteral stents. Furthermore, rising patient awareness regarding treatment options for urological conditions propels market growth. Moreover, favorable reimbursement policies and a strong focus on innovation in stent technology further support the expansion of this market segment within the country.

Asia Pacific Ureteral Stents Market Trends

The Asia Pacific ureteral stents market is expected to grow at a CAGR of 7.8% over the forecast period, driven by an expanding aging population and rising incidences of kidney-related disorders. Improving healthcare infrastructure in developing countries enhances access to advanced medical devices. In addition, increased urbanization and lifestyle changes contribute to a higher prevalence of urological issues, while growing medical tourism in countries like India and China further stimulates demand. Furthermore, government initiatives to improve healthcare spending are crucial in market expansion across this region.

The ureteral stents market in China dominated the Asia Pacific market and accounted for the largest revenue share in 2023, owing to a significant rise in urological disorders linked to lifestyle changes and dietary habits. In addition, the increasing aging population exacerbates the prevalence of kidney stones and urinary complications. Furthermore, healthcare infrastructure and technology advancements have improved access to effective treatment options.

Europe Ureteral Stents Market Trends

The growth of Europe ureteral stents market is driven by favorable demographics, including an aging population susceptible to kidney-related diseases. In addition, the region boasts well-established healthcare systems that facilitate advanced treatment options for urological conditions. Furthermore, increasing awareness about minimally invasive procedures and technological advancements in stent design enhance patient outcomes. Moreover, collaborations between healthcare providers and manufacturers foster innovation in product development, further propelling market growth across various European nations.

Germany ureteral stents market led the North American market and accounted for the largest revenue share of 26.2% in 2024 attributed to its robust healthcare infrastructure and high standards of medical care. In addition, the country faces a rising incidence of kidney disorders, prompting increased demand for effective treatment solutions such as ureteral stents. Furthermore, a strong emphasis on research and development within German medical institutions leads to innovative product offerings that cater to patient needs.

Key Ureteral Stents Company Insights

Some of the key companies in the market include B.Braun Melsungen AG, Boston Scientific Corporation, Coloplast, Cook Medical, and others.  These companies employ various strategies to maintain a competitive edge. To enhance patient outcomes, they focus on new product launches incorporating advanced technologies, such as biodegradable materials and antibacterial coatings. In addition, strategic collaborations and partnerships with healthcare institutions facilitate research and development, leading to innovative solutions. Furthermore, mergers and acquisitions enable companies to expand their product portfolios and market reach, ensuring they remain leaders in the evolving medical device landscape.

• B. Braun Melsungen AG manufactures a range of products, including ureteral stents designed to effectively manage urological conditions. The company focuses on segments such as hospital care, surgical instruments, and infusion therapy, ensuring high-quality solutions that meet the needs of healthcare professionals. Its commitment to innovation and patient safety positions it as a key contributor to advancements in ureteral stent technology.

• Boston Scientific Corporation produces various urological devices, including advanced ureteral stents designed to address complications like encrustation and urinary obstruction. The company operates across multiple segments, including cardiovascular, rhythm management, and urology, emphasizing innovative solutions that enhance patient outcomes. Their recent developments in stent technology reflect a strong focus on research and development, solidifying their competitive position in the market.

Ureteral Stents Market Report Scope

Global Ureteral Stents Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global ureteral stents market report based on material, application, and region:

• Material Outlook (Revenue, USD Million, 2018 - 2030)

  • Metallic Ureteral Stents

  • Polymer Ureteral Stents

    • Silicone Stents

    • Polyurethane Stents

    • Hybrid Stents

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Kidney Stones

  • Kidney Transplantation

  • Tumors

  • Urinary Incontinence

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • India

    • China

    • Japan

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • Kuwait

    • Saudi Arabia

    • South Africa

    • UAE